whereas pathophysiologically relevant concentrations as found in patients with mild hyperhomocysteinemia seem to induce functional endothelial changes summarized as endothelial dysfunction [13] . Recently, it has been shown that exposure of cultured EC to Hcy leads to endothelial activation with increased expression of chemokines, like MCP-1 and IL-8 [14] and adhesion molecules [15, 16] . [17] . [18] . [19] . Recently, it has been observed that PPAR-␥ agonists decrease hyperhomocysteinemia and cardiac dysfunction [20] . In addition, PPAR-␥ which is expressed in vascular EC [21] ameliorates the Hcy-induced EC activation [22] . 
It has been reported that Hcy increases the production of reactive oxygen species (ROS) from T lymphocytes and their proliferation rate in ApoE-deficient mice maintained under high-methionine diet, insinuating that hyperhomocysteinemia may be involved in the pathogenesis of atherosclerosis by enhancing T cell response

Moreover, Hcy enhances ROS production in EC and activates NF-B which triggers increased Intercellular Adhesion Molecule 1 (ICAM-1) expression and adhesion of monocytes
Due to its anti-inflammatory, and antioxidant actions, the peroxisome proliferator-activated receptor-␥ (PPAR-␥) family of nuclear hormone receptors has been intensively investigated in models of vascular inflammation. Activation of PPAR-␥ counteracts the induction of pro-inflammatory chemokines, such as MCP-1 in cytokinetreated human vascular EC
In this study we investigated whether relevant pathophysiological levels of Hcy modulate the CXCL16 expression on EC and recruitment of CXCR6 + lymphocytes in vitro and in vivo via a PPAR-␥-dependent mechanism.
Materials and methods
Chemicals
D,L-Hcy, L-Hcy thiolactone hydrochloride and L-Cys were from Sigma Chemical Co. and freshly prepared first as 100 mM stock solutions in Dulbecco's Modified Eagle's Medium (DMEM) medium supplemented with 10% FBS. L-Hcy was synthesized from its thiolactone by hydrolysis in 0.1 M NaOH [23]. Tumour necrosis factor (TNF)-␣, interferon (IFN)-␥ and
Cell lines
Human embryonic kidney epithelial cell (HEK293) line was transfected with the human CXCR6 receptor [24] . EA.hy926 cell line [25] [28] . Figure 1 [11] . By contrast, in L-Cys-treated ECs the CXCL16 expression was similar to that in unstimulated cells.
Fluorescent labelling of cells
In vivo model of peritoneal inflammation
One millilitre of Hcy and/or other chemicals dissolved in PBS was injected in the peritoneum of each wild-type C57-Black6 mouse used for the experiment (three independent experiments, three mice per condition
Results
CXCL16 expression on homocysteine-activated endothelial cells
To investigate whether pathophysiological relevant concentrations of Hcy would influence the endothelial expression of CXCL16, RT-PCR analysis of Hcy-stimulated EC using CXCL16 specific primers was performed. As shown in
Next, CXCL16 surface expression was determined by flow cytometry (Fig. 1B and C) Fig. 2B and C) and, more importantly, also human CXCR6 + lymphocyte adhesion to EC (Fig. 3C ). These findings demonstrate a significant involvement of CXCL16 in increased adhesiveness of Hcy-activated EC. (Fig. 4) (Fig. 4) . These data indicate that the scavenger receptor activity of CXCL16 contributes to increased oxLDL uptake by Hcy-activated EC.
CXCL16-mediated uptake of oxidized LDL by homocysteine-stimulated endothelial cells
Effect of antioxidants and PPAR-␥ modulators on homocysteine-induced CXCL16 expression and function
Since the antioxidant Tiron significantly reduced Hcy-induced CXCL16 expression we further investigated whether oxidative stress modulators would affect CXCL16 up-regulation and function. Co-incubation of EC with L-Hcy together with the antioxidant Tiron significantly diminished Hcy's stimulatory effect on oxLDL binding and adhesion of CXCR6-HEK293 cells or CXCR6
+ lymphocytes (Fig. 5A, B 
and C). Similarly, the PPAR-␥ agonist Pioglitazone significantly reduced oxLDL binding and cell adhesion. Co-incubation with GW9662, an antagonist of PPAR-␥, slightly increased Hcy-induced oxLDL uptake and CXCR6
+ lymphocyte adhesion to EC (Fig. 5A and B ). 
Expression and function of CXCL16 in hcy-incubated primary endothelial cells
Peritoneal recruitment of CXCR6+ lymphocytes after homocysteine injection
To study the potential involvement of CXCL16 in the proinflammatory activity of Hcy in vivo, Hcy or L-Cys were injected in the murine peritoneum and after 4 days cells were harvested from the peritoneal cavity by lavage. Flow cytometric analysis of these cells for expression of CXCR6 revealed that injection of Hcy but not L-Cys induced an accumulation of CXCR6
+ lymphocytes (Fig. 6 ). [29] . As seen in ApoE-deficient mice maintained under high methionine diet, hyperhomocysteinemia may be involved in the pathogenesis of atherosclerosis by enhancing the T cell response [17] . [14, 30] and in human monocytes [31] . These chemokines are key attractants for neutrophils and monocytes [4] . Our data provide evidence that Hcy also induces CXCL16 which functions as a potent attractant and adhesionmolecule for CXCR6 + T lymphocytes [5, 6] . The involvement of CXCL16 in atherosclerosis has first been suggested by the observation of its expression in atherosclerotic plaques [7, 8] . Moreover, T cells co-localize with CXCL16-expressing EC in plaques [8] and T cell infiltration into the lesions has been found to be reduced in ApoE-deficient mice with targeted disruption of the CXCR6 gene [32] . [2] . Several recent studies have indicated that scavenging of oxLDL is also mediated by CXCL16 [8, 9] [32, 35] .
Co-injection together with Pioglitazone or anti-CXCL16 antibody reversed the stimulatory effect of Hcy on the recruitment of
Fig. 4 Hcy's stimulatory effect on uptake of DiI-labelled oxLDL by endothelial cells. (A) EA.hy926 cells were assayed for binding of DiI-oxLDL by flow cytometry. (B) Binding of DiI-oxLDL to EC was significantly increased by 24 hrs stimulation of EC with Hcy but not by treatment with L-Cys (n = 4 experiments; *P<0.05 versus untreated control cells). Pre-incubation of Hcy-activated ECs with neutralizing antibody against CXCL16 significantly dimished the uptake of oxLDL ( $ P<0.05 versus L-Hcy only). (C) Representative photomicrographs indicate increased uptake of oxLDL by Hcy-treated EC.
Fig. 5 Effect of reactive oxygen species (ROS) scavenger (Tiron), agonists (Pioglitazone) and antagonists (GW9662) of peroxisome proliferatoractivated receptor-␥ (PPAR-␥) on oxLDL binding and adhesion of CXCR6 + lymphocytes to homocysteine-stimulated endothelial cells. 24 hrs incubation of EA.hy926 cells with Hcy together with Tiron or Pioglitazone but not GW9662 (5M) significantly diminished oxLDL binding (A), adhesion of CXCR6-HEK293 cells (B) and CXCR6-sorted primary human lymphocytes (C). (n = five experiments
Previous findings have indicated that Hcy induces the expression of MCP-1 and IL-8 in human aortic EC
Oxidative stress has been implicated in hyperhomocysteinemia-induced endothelial dysfunction. PPARs known as proantioxidants are expressed in vascular EC [21, 36, 37] and a negative correlation between high levels of Hcy and PPAR expression has been already demonstrated [38] . In a previous study we 
